Sian Bigora insider trades
Open-market stock purchases and sales by Sian Bigora, Chief Development Officer at Processa Pharmaceuticals, Inc, from SEC Form 4 filings since Jun 8, 2021.
Track record: 0% of 4 scored buys are up 5% or more since purchase, averaging -25%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 30, 2026 | PCSA Processa Pharmaceuticals, Inc | Bought | $5.3K |
| Apr 30, 2026 | PCSA Processa Pharmaceuticals, Inc | Bought | $5.3K |
| Apr 15, 2026 | PCSA Processa Pharmaceuticals, Inc | Bought | $5.3K |
| Mar 31, 2026 | PCSA Processa Pharmaceuticals, Inc | Bought | $5.3K |
| Jan 1, 2026 | PCSA Processa Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- PCSA Processa Pharmaceuticals, Inc: 4 buys, last Apr 30, 2026